共 50 条
Editorial: Overcoming drug relapse and therapy resistance in NSCLC
被引:2
|作者:
Parakh, Sagun
[1
,2
,3
]
Leong, Tracy L.
[4
,5
,6
,7
]
Best, Sarah A.
[6
,7
]
Poh, Ashleigh R.
[3
,8
]
机构:
[1] Austin Hlth, Dept Med Oncol, Heidelberg, Vic, Australia
[2] Olivia Newton John Canc Res Inst, Tumor Targeting Lab, Heidelberg, Vic, Australia
[3] La Trobe Univ, Sch Canc Med, Melbourne, Vic, Australia
[4] Austin Hlth, Dept Resp Med, Heidelberg, Vic, Australia
[5] Univ Melbourne, Fac Med, Parkville, Vic, Australia
[6] Walter & Eliza Hall Inst Med Res, Personalised Oncol Div, Parkville, Vic, Australia
[7] Univ Melbourne, Dept Med Biol, Melbourne, Australia
[8] Olivia Newton John Canc Res Inst, Canc & Inflammat Lab, Heidelberg, Vic, Australia
来源:
基金:
英国医学研究理事会;
关键词:
drug resistance;
non-small cell lung cancer;
metabolism;
tumor microenvironment;
biomarkers;
tumor mutational burden (TMB);
EGFR mutation;
immunophenotyping;
D O I:
10.3389/fonc.2023.1230475
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
引用
收藏
页数:3
相关论文